Glucagon-like peptide-1 (GLP-1) receptor agonists are medications primarily used for managing type 2 diabetes and, in some formulations, for weight management in adults with BMI 30 kg/m or 27 kg/m with weight-related comorbidities
Understanding the nuances of each condition can significantly aid in distinguishing between them, as they may present with overlapping symptoms but necessitate different management strategies
Rybelsus 3mg tablets should be taken on an empty stomach, at least 30 minutes before the first food, drink, or other oral medications of the day, with no more than 120 ml (approximately half a cup) of plain water swallowing the tablet whole without crushing or chewing it
Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with type 2 diabetes mellitus and obesity: a randomized dose-ranging study
J.H.H was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korea Government (MSIT) (No
A.HanyalogluA